JGC
CLB icon

J. Goldman & Co’s Core Laboratories CLB Stock Holding History

J. Goldman & Co’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-35,000
Closed -$4.2M – 334
2016
Q4 		$4.2M Buy
+35,000
New +$3.88M 0.28% 113

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

J. Goldman & Co's CLB Position: Q1 2017 in Review

J. Goldman & Co sold out of Core Laboratories (CLB) in Q1 2017, closing a stake of 35,000 shares — an estimated $4.2M sold.

J. Goldman & Co first reported a position in CLB in Q4 2016 and held it in 1 quarter. The position peaked at $4.2M in Q4 2016. 360 funds tracked by Wall St. Rank hold CLB as of Q1 2017.

  • J. Goldman & Co reported no remaining Core Laboratories position as of Q1 2017 after selling out during the quarter.
  • J. Goldman & Co sold 35,000 Core Laboratories shares in Q1 2017, an estimated $4.2M.
  • J. Goldman & Co first reported a position in Core Laboratories in Q4 2016 and held it in 1 quarter.
  • J. Goldman & Co's Core Laboratories position peaked at $4.2M in Q4 2016.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2017.

Based on J. Goldman & Co's 13F filing for Q1 2017, filed 15 May 2017.